Glenmark Pharma share price tumbles 5% on price-fixing allegations in US

The charge was filed in US District Court in Philadelphia. The price-fixing conspiracy allegedly took place from 2013 to 2015 and caused a loss to victims of at least $200 million, according to the department.

Read Full Story on MoneyControl

Enter your email address:

Leave a Reply

Your email address will not be published. Required fields are marked *